PACIRA BIOSCIENCES, INC. (PCRX) Operating margin 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) operating margin by fiscal year — reported operating income divided by reported revenue.
2.6%FY2025 · since FY2016: -11.9% → 2.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.6% | +13.1 pp |
| FY2024 | -10.5% | -23.5 pp |
| FY2023 | 13.0% | +4.0 pp |
| FY2022 | 9.0% | -7.6 pp |
| FY2021 | 16.6% | +5.8 pp |
| FY2020 | 10.8% | +8.3 pp |
| FY2019 | 2.5% | -2.3 pp |
| FY2018 | 4.8% | +13.6 pp |
| FY2017 | -8.8% | +3.1 pp |
| FY2016 | -11.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice